Clariant Valuation Multiples

Discover Clariant's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Solvay, Ashland, H.B. Fuller, Azelis Group and more.

Clariant Overview

About Clariant

Clariant AG is a Switzerland-based specialty chemicals company with world-wide operations. The company reports in three business areas: care chemicals, absorbents and additives and catalysts. Care chemicals mainly targets consumer end markets such as personal care and homecare, but it also has an industrial component. Absorbents and additives encompass Clariant’s coatings and adhesives, absorbents, and plastics segments. Catalysts manufacturers process catalysts, mainly for petrochemical and syngas plants.


Founded

1995

HQ

Switzerland

Employees

10.5K

Sectors

Financials (LTM)

Revenue: $4.9B
EBITDA: $844M

EV

$4.8B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Clariant Financials

Clariant reported last 12-month revenue of $4.9B and EBITDA of $844M.

In the same LTM period, Clariant generated $1.5B in gross profit, $844M in EBITDA, and $104M in net income.

Revenue (LTM)


Clariant P&L

In the most recent fiscal year, Clariant reported revenue of $5.1B and EBITDA of $884M.

Clariant is unprofitable as of last fiscal year, with gross margin of 29%, EBITDA margin of 17%, and net margin of (2%).

See analyst estimates for Clariant
LTMLast FY202320242025202620272028
Revenue$4.9B$5.1B$5.4B$5.2B$4.9B
Gross Profit$1.5B$1.5B$1.4B$1.6B$1.5B
Gross Margin31%29%25%30%30%
EBITDA$844M$884M$698M$865M$466M
EBITDA Margin17%17%13%17%10%
EBIT Margin11%11%5%9%8%
Net Profit$104M($93M)$167M$303M($93M)
Net Margin2%(2%)3%6%(2%)
Net Debt-$1.8B---

Financial data powered by Morningstar, Inc.

Clariant Stock Performance

Clariant has current market cap of $3.2B, and enterprise value of $4.8B.

Market Cap Evolution


Clariant's stock price is $9.63.

Clariant share price increased by 10.3% in the last 30 days, and decreased by 10.1% in the last year.

Clariant has an EPS (earnings per share) of $-0.28.

See more trading valuation data for Clariant
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$4.8B$3.2B-0.5%10.3%-5.4%-10.1%$-0.28

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Clariant Valuation Multiples

Clariant trades at 1.0x EV/Revenue multiple, and 5.7x EV/EBITDA.

See NTM and 2027E valuation multiples for Clariant

EV / Revenue (LTM)


Clariant Financial Valuation Multiples

As of July 17, 2026, Clariant has market cap of $3.2B and EV of $4.8B.

Clariant has a P/E ratio of 30.4x.

LTMLast FY202320242025202620272028
EV/Revenue1.0x1.0x0.9x0.9x1.0x
EV/EBITDA5.7x5.5x6.9x5.6x10.4x
EV/EBIT9.3x8.9x16.2x10.1x12.5x
EV/Gross Profit3.2x3.3x3.5x3.1x3.3x
P/E30.4x(34.0x)19.0x10.4x(34.0x)
EV/FCF14.7x14.2x18.2x18.6x14.2x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Clariant Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Clariant Margins & Growth Rates

Clariant decreased revenue by 7% and EBITDA by 8% in the last fiscal year.

In the most recent fiscal year, Clariant reported gross margin of 29%, EBITDA margin of 17%, and net margin of (2%).

See estimated margins and future growth rates for Clariant

Clariant Margins

Last FY202420252026202720282029
Gross Margin29%30%30%32%
EBITDA Margin17%17%10%17%
EBIT Margin11%9%8%11%
Net Margin(2%)6%(2%)6%
FCF Margin7%5%7%8%

Clariant Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(7%)(5%)(6%)(4%)
Gross Profit Growth3%14%(7%)3%
EBITDA Growth(8%)24%(46%)74%
EBIT Growth(9%)60%(19%)28%
Net Profit Growth(394%)82%(131%)(394%)
FCF Growth5%(2%)31%5%

Data powered by FactSet, Inc. and Morningstar, Inc.

Clariant Operational KPIs

Clariant's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.1M for the same period.

Clariant's Rule of 40 is 14% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Clariant's Rule of X is 8% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Clariant
LTMLast FY202320242025202620272028
Rule of 4016%14%---
Bessemer Rule of X13%8%---
Revenue per Employee-$0.5M---
Opex per Employee-$0.1M---
G&A Expenses to Revenue20%19%16%18%19%
R&D Expenses to Revenue3%3%4%3%3%
Opex to Revenue-21%20%21%22%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Clariant Competitors

Clariant competitors include Solvay, Ashland, H.B. Fuller, Azelis Group, Kuraray Co, Enaex, Gubre Fabrikalari, Hawkins, Mitsubishi Materials and Shanghai Petrochemical.

Most Clariant public comparables operate across Chemicals.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Solvay0.9x1.0x4.9x5.3x
Ashland2.3x2.3x10.7x11.1x
H.B. Fuller1.5x1.4x8.2x7.8x
Azelis Group1.0x1.0x9.2x9.2x
Kuraray Co0.9x0.8x4.8x4.9x
Enaex1.7x-11.8x-
Gubre Fabrikalari2.6x-12.3x-
Hawkins3.0x2.9x18.0x17.6x

This data is available for Pro users. Sign up to see all Clariant competitors and their valuation data.

Start Free Trial

Acquisitions by Clariant

Clariant has acquired 6 companies to date.

Last acquisition by Clariant was on October 30th 2023. Clariant acquired Lucas Meyer Cosmetics for $810M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Clariant

Lucas Meyer Cosmetics
BASF (Attapulgite unit)
Beraca
Kel-tech
Description
Lucas Meyer Cosmetics is a Toulouse-headquartered developer and manufacturer of cosmetic active ingredients and delivery systems, now part of Clariant Group following its 2015 acquisition. The company supplies botanical extracts, peptides, and encapsulation technologies for skincare, haircare, and makeup formulations. It supports global brands with formulation expertise, regulatory compliance, and technical services from facilities in Europe and the United States.
BASF's Attapulgite unit produces rheology modifiers derived from attapulgite clay mined in Georgia, USA, for applications in paints, adhesives, drilling fluids, and suspensions. Products like Attagel and Attapulgite grades range from 200 mesh fine powders to 60/40 coarse granules, providing thixotropy and suspension stability in water-based systems. The unit supplies industrial manufacturers globally from facilities in Valdosta, Georgia, supporting formulations that meet API standards for oilfield chemicals.
Beraca is a Brazil-headquartered supplier of sustainable natural ingredients for personal care and cosmetics. Sourced from the Amazon rainforest, its portfolio includes açaí oil, cupuaçu butter, and andiroba extracts harvested through community-managed agroforestry programs. Certified organic and fair trade, these botanicals serve global formulators in skincare, haircare, and sun protection products. Founded in 1994 with extraction facilities in São Paulo state, Beraca exports to over 40 countries emphasizing biodiversity preservation.
Kel-tech is a Permian Basin-based specialty chemical supplier to the oil and gas sector, founded in 1983. The company serves production, field stimulation, and drilling operations with tailored chemical products essential for upstream activities in Texas and surrounding regions.
HQ CountryFranceGermanyBrazilUnited States
HQ City
Champlan
Mannheim
São Paulo
Midland, TX
Deal Date30 Oct 202328 Dec 202123 Aug 202114 Sep 2016
Valuation$810M$60Mundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Clariant acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Clariant

Clariant has invested in 1 company to date.

Latest investment by Clariant was on April 12th 2016. Clariant invested in BioSpectrum in their $8M Series A round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Clariant

BioSpectrum
Description
BioSpectrum is a life sciences ingredient manufacturer headquartered in Morrisville, North Carolina. The company produces natural extracts from marine algae and plants for cosmetics, personal care, and nutraceuticals, including stem cell activators, anti-inflammatory blends, and pigmentation control compounds sourced sustainably from global ocean regions.
HQ CountrySouth Korea
HQ City
Seongnam
Deal Date12 Apr 2016
RoundSeries A
Raised$8M
InvestorsClariant
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Clariant investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Clariant

When was Clariant founded?Clariant was founded in 1995.
Where is Clariant headquartered?Clariant is headquartered in Switzerland.
How many employees does Clariant have?As of today, Clariant has over 10K employees.
Is Clariant publicly listed?Yes, Clariant is a public company listed on SIX Swiss Exchange.
What is the stock symbol of Clariant?Clariant trades under CLN ticker.
When did Clariant go public?Clariant went public in 2001.
Who are competitors of Clariant?Clariant main competitors include Solvay, Ashland, H.B. Fuller, Azelis Group, Kuraray Co, Enaex, Gubre Fabrikalari, Hawkins, Mitsubishi Materials, Shanghai Petrochemical.
What is the current market cap of Clariant?Clariant's current market cap is $3.2B.
What is the current revenue of Clariant?Clariant's last 12 months revenue is $4.9B.
What is the current revenue growth of Clariant?Clariant revenue growth (NTM/LTM) is (2%).
What is the current EV/Revenue multiple of Clariant?Current revenue multiple of Clariant is 1.0x.
What is the current EBITDA of Clariant?Clariant's last 12 months EBITDA is $844M.
What is Clariant's EBITDA margin?Clariant's last 12 months EBITDA margin is 17%.
What is the current EV/EBITDA multiple of Clariant?Current EBITDA multiple of Clariant is 5.7x.
What is the current FCF of Clariant?Clariant's last 12 months FCF is $329M.
What is Clariant's FCF margin?Clariant's last 12 months FCF margin is 7%.
What is the current EV/FCF multiple of Clariant?Current FCF multiple of Clariant is 14.7x.
How many companies Clariant has acquired to date?As of July 2026, Clariant has acquired 6 companies.
What was the largest acquisition by Clariant?$810M acquisition of Lucas Meyer Cosmetics on 30th October 2023 was the largest M&A Clariant has done to date.
In how many companies Clariant has invested to date?As of July 2026, Clariant has invested in 1 company.
What was the last Clariant investment?On 12th April 2016 Clariant invested in BioSpectrum, participating in a $8M Series A round.
In what companies Clariant invested in?Clariant invested in BioSpectrum.

See public comps similar to Clariant

Lists including Clariant

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial